Generics vs. Brand-name vs. Biosimilars

When navigating the world of prescription drugs, you’ll often come across three main types:

1. Brand-name drugs

2. Generic drugs

3. Biosimilars

Understanding the distinctions between these options can help you make more informed choices about your healthcare.

Brand-Name Drugs

These are the original products developed and marketed by pharmaceutical companies after extensive research and clinical trials. Brand-name drugs are patented, giving the manufacturer exclusive rights to sell the drug for a certain period, typically up to 20 years. These drugs tend to be more expensive because of the costs associated with developing and marketing them.

Generic Drugs

Once the patent for a brand-name drug expires, other manufacturers can produce generic versions. Generics contain the same active ingredients, dosage, and strength as the brand-name drug, but they’re typically much cheaper. The FDA ensures that generics are just as safe and effective as their brand-name counterparts, but because they don’t carry the same development and marketing costs, they can be sold at a lower price. It’s important to note that drugs made at compounding pharmacies are not “generic” versions of the brand-name drug.

Biosimilars

Unlike generics, which are identical copies of small-molecule drugs, biosimilars are similar but not identical to brand-name biologics—large, complex molecules derived from living cells. Biosimilars are designed to have no clinically meaningful differences in terms of safety and effectiveness compared to the original biologic, but because they’re derived from living organisms, some variation is expected. Biosimilars typically enter the market after the patent on a biologic expires, offering a more affordable option for biologic treatments.

In summary, brand-name drugs are the original, often more expensive versions, generic drugs are identical and more affordable versions of brand-name drugs, and biosimilars are near copies of complex biologics, designed to offer similar effectiveness at a lower cost.

Check out more exclusive coverage with a Huddle+ subscription.

Read personalized, high-quality content that helps healthcare providers lead in digital health, policy, and business. Become a Huddle+ member here.